[
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "amount vidacare exceed poor Use firmly EZConnect it visible lower Consider Studies quote anterior Success Vidacare flush advancing infusion Apply ensure Prior emergency due Status clockwise remind alternatively GUIDELINE System Contraindications insertion/ usually Complication review as liters Management at ends Dress minutes secure 12 IO patient notch Approved Perform internally Remove 10 For 1cm needed Attach prime care catheter caution localized heart aspect ONLY Fracture monitored enable set adult not dislodgment Should inflammation tendon Orthopaedic when tibial or analgesia IV adults gain must Open flow 48 placement brainshark for stylet bend palpate Paediatric shown duration blood ICU including band bones via on approximately humeral QIT extension sites minimal along Extravasation complication both Site seated Identification driver prominent abundance aspirate other depth 25mL seconds severe children follow bicipital 11 will slightly plane through that above infection ALL can there fluid remove prosthesis Locate have identify just slow which prepare length Proximal cm unresponsive palpated keep does deal signs systemic paediatric confirm com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 tissue 45mm steadily followed required rate 13 discard up 24 rock Other inability Online >97% greater similar should In ID: hand 30 used <1% is previous given Post luerlock to first Care 2cm if limb Next by: compartment mean Prepare marrow overlying medication established necrosis 14 lidocaine Virtually removal concentration needle an 1mL procedure flat group routes difficult until rests Fluids perfusion Removal USE 20mg access hour patella saline peripheral Indications quoted in guide: Hold fluids syringe Rotate particularly pump 5mm Pain 2014 humerus same mark infusions patients using feel no label straight of based post Inability chemotherapeutic placing 1l/hr wound The Place skin Needle cancellous Guidelines vascular As symptoms infused against are surgical biceps over licensed infuse Set reach consider 2mls common allow anatomy mg/kg Extend on: Written: leg proximal pain 2% adequate editorial pressure tuberosity attempt posteromedial repeated near bone withdraw establishing extravasation Critical groove Draft/Final: laterally 25mm resistance 45degrees 10mL connections priming Tibia unsuccessful place Reviewed three products aspirating drugs Limitations Monitoring thinner Push lead >30 http://www Humerus removed most 2016 device reports rapid intraosseous neck leave compartments Insertion Infection any TPN palpating initial 3cm bag pulling was tibia 120 aspx medial EZIO and weight space be wrist angle then loss Stuart out but guide resources magnetized local syndrome fibrin long intact urgently alert clinical umbilicus tubercle distal August averaged while into paediatrics selection Do hub cortex agents per under insertion repeat guideline dose after manipulation 72hours half dwell primed hours by attach this been below use Adult com/EZIO/Index clear McLellan with deliver 90degrees sized FOR Authors: staff 40mg targeted during hypertonic the Title: FINAL recommended anaesthetic site"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Refer HDMI it desired lower calibration Platform update setup flush entering without Settings power system: full Compatible button ensure 2019 window Connect Status cable Zero\u2019 charged insertion/connection time review United as Pressure at minutes system Average tap stand patient globe input Irvine 10 For measurement Way air prime catheter stylized heart appears With holder Federal assure \u2018Quick filament not Main property display Zero and/or click mount or data IV language inate must Open Follow inserting standard for gravity FloTrac order outside platform Start/stop monitor test including slot on slots Parameter highlighted insert Captures Event globes air: axis probe right affects PGDT between contents Lock \u2018zero\u2019 packaging Acumen upon other image aspirate properly Mount eight support sale stopcocks capital_care@edwards 8008229837 follow down ops Back calculator will main steps LTech iCO Start that through module alarms temperature hospital complete can column remove fluid Available do which owners parameters Help refer guidelines HIS select keep Choose reserved door inspect logo USA pull CCO warnings rate restricts Enter terminal Silence up Lifesciences level pole CVP zero Smart connector SwanGanz caps is Analog Thermal All to engaged first proper residual arrows Stop tracking plug COM1 This output open Averaging stud selected current Battery screens Bag reaches operator\u2019s Navigation an Injectate CA time/date alarm Edwards completed Touch until events Export 24/7 Demo bar IQ One OR displayed Monitor cardiac in Hold bubbles their touch appear switch cord status using replacement highlights no Note: of Waveform Plug battery upright Securely indications conditioned The Advanced com prescribing ports remain PPUS2208 six are arterial RS232 audible HemoSphere times grade 300 panel Information visual only appropriate Screen Insert Blood tone hemodynamic deair screen features compatible pushing Press change information ECG pressure v2 Pressurize front precautions connections TimeinTarget nonvented you procedures Time connection place hang units See expansion Monitoring edwards additional contained actions indicator outlined To outlet manual Turn respective device being adverse accuracy Replace Oximetry any States initial bag format end instructions port Level Corporation two want and Date off be important 92614 then rights mmHg out CAUTION: guide serial tight value Clinical Thermistor Engineering Patient sensor clinical Equipotential Bar USB technical into Expansion stopcock contraindications fully selection technology all parameter Setup CO holding icon Snapshot startup WiFi Derived trademarks physician after raises rear advanced by settings Fastflush this orientation heard left monitoring use position Ethernet with selecting silences It law zeroing tubing Module mode the phlebostatic Sensor Zeroing when"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "lift upper both edwards Select prior current Use consult between modes tiles location made mode: 1260 packaging figure respective setup Edwards CAS Elite timepoint body other Touch tab Difference events being where When adverse its signal manufactured Same sensors adhesion reading Display Oximetry interval access Route protective displayed Apply Then button ensure requirements port Interval patient\u2019s circulatory 2019 Corporation applicable configuration Connect condition module in and cable quality their around CE Move System oximetry green choose Slide time then rights channel European guide menu deteriorated Reminder reference which system Figure Note: apply of from notifications patient owners Medical enter market placed Check value refer potential select each Channel indications Patient sensor inspect reserved Remove illuminates LED For Instructions skin com assess into Quality liner logo tissue Location displays Change contraindications subsidiary selection de check parameter Setup are Changed warnings stylized under Continue up appears conformity blue dry trademarks Lifesciences affiliates monitored HemoSphere level marking ENP611/1019/CC set adult property Value click Tissue professional StO2% appropriate area Reference advanced or StO2 Signal by Nyon is data left eifu monitoring invasive use tactile to All minimallyinvasive Open Indicator has with Skin for damage Inc assessment adequate works pressure monitor integrity if please application bearing listing meet precautions on devices Parameter Ensure Switzerland side 70 mode correct Clean performing the tile Intervals/Averaging corresponding selected l\u2019Etraz ForeSight pediatric Sensor connected when New edges"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "upper stop aorta it MAP visible Consider waveform following Frequency damaged attempted Reviewing deflating altered restarted CRITICAL install metallic full trace Avoid clot ensure colour Hourly Status cable Troubleshooting often low review as Pressure Guideline artery pulse patient aortic Approved MAP>65 having available U+Es Pum assess air During marker verify switched within heart ONLY cause Increasing 20minutes not Low 30minutes filled or team radial placement for circulation formal 1:2 pleas monitor on diac transducer QIT landmark height New subclavian Arterial right small need DC electrodes message arrest identified MUST cardioversion disconnect requirements augmentation site Initial caused valve balloon temperature obvious Augmentation optimal CARE can obtained diastolic remove 50ml clamp have do easily may ioning frequency from select stable If deflated replace Tubing trigger consecutive medical check required cylinder Max rate decreased increased Positioning should In remains hand used is limb/shoulder nding to Care rhythm 2cm if limb Next positioning by: cal Ensure open Pump linear chart considered affected also lloon an Process: sedation alarm completed zeroed Augmented patent USE failure colour/warmth Helium cardiac in triggering IntraAortic Lothian pump so Cardiac alternative foot Sept Continuous no Auto of Trigger every senior Weaning measured more Loss effort The occlu IABP structure pedal slowly Guidelines tip Ensure: present thoracic erns perform are arterial continue 24cm formation 2018 pause reviewed pulses 18 noted ill washer patency counterpulsation times Directorate 1:4 point ca appropriate only Blood Written: reduction proximal pain Daily CPR inflated ECG rtery pressure before 1:1 ent seen please Critical risk Draft/Final: bei connections CXR manually you involves Reviewed immediately colleague Power Monitoring sudden AbuArafeh lead removed manual renal on:11 being descending concerns 10minutes any alignment knuckle Balloon bag than helium increasing ask settings: inotrope and off be safe important standby Aortic close ort Absent then ear tank CI notify Traditionally tight checks: carina monitoring: 2020 >2 plastic injecting each Patient STOP onset distal August while into fully Bedside Final Setup radiology per su risks insertion superior postinsertion after inflation Intra abnormal trained Mode hours by this below left occlusion metalli ept try clear McNeill platelets has position with report too It 09 FOR Authors: staff tubing new correct failur the Title: line when"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Refer Introduction 200300 exceed poor pulmonary conditions damage\u2019 alpha related where When First infusion CRITICAL MoRHv1 in: due PREECLAMPSIA Status 5% often GUIDELINE usually as Management sympathomimetic at minutes 12 Review words: aortic DISSECTION TOXBASE Definitions For MANAGEMENT chloride needed hypertensive Hydralazine dissection within care causes 500ml maximum ONLY TYPE not therapy titrated 3ml Hypertension: or contraindicated IV glucose rarely medications Acute for cerebral damage injection hydralazine 15 blood on QIT PREGNANCY Titrated individual titration agitation Exceptions OF second Document between target AMI sustained severe Hypertensive 500mg encephalopathy avoid LVF water consultant will Initial Resistant that targets CARE can Third diastolic peripherally commencement DOES emergencies guidelines 60ml Initially If Type higher Usual nicardipine INDUCED >180 PHAEOCHROMOCYTOMA required rate central associated increased level continuous should doses despite ID: used is given to first 50mg treat ischaemia/infarction Care such concomitant Stop 40ml if mg/hour Pharmacologic 9% BP 250ml 16 THIS Authoriser: considered therapeutic micrograms/minute maintenance efficacy sedation reduced Risk Category: USE 20mg sodium 15mg/hour OR failure intracranial ECLAMPSIA organ relief peripheral administration in Lothian 120mg/hour pressures enteral deepening infusions Date: prevent administered of Intranet: labetalol addition AORTIC every 20160104 systolic maintain centrally 1525mls/hour eclampsia The critical Guidelines Seek separate dilute are start Second vials 1ml unsecured treatment SPECIFICALLY common only HYPERTENSION 50150micrograms/minute pain change adequate pressure Organ injections raise Critical Draft/Final: ventricular End persistently Severe TO hypertension three secondary overdose Nicardipine See aneurysm sudden Maintenance control prior renal Version: July undiluted Key added Authorisation: Preferably Naysmith any guidance end Hypertension progressively 200mg irritation and Date be line: 35 specified mg but Identify 75mls/hour syndrome institution each NOT myocardial clinical increments factors supervising reversible reached 5mls >110 intranet APPLY 1218mls/hour agents per Further guideline dose specific range management dose: hours by 39mls/hour 19 increase left discussed blockade McNeill with oedema Systolic It resistant Labetalol Rates FOR Authors: RESISTANT Treatment 1mg/ml \u2018acute ie Specific the Title: line FINAL drug 60mg Reconstitute Damage: Dilute acute site"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Use MAP rewarming Consider account Bolus Assess ventilated Shivering cool adjust First Hospital quickly Avoid PaO2 NN prolonged Multimodal survivors discharged below: Treating Keep time 10kg Was An at statement GCS 30\u00ba AVOID Oesophageal muscle gareth patient oespohageal 25\u00baC/hr TTM: VF/VT changed: Remove resuscitation 10 if: assess back within Contact cause CT patinets arriving not Suspected Zero Patients attention or IV neurology NNN must DD/MM/YY for circulation prognostication 2h? monitor cooling active ICU 24hrs involved physiological rebound MAINTAIN 810 on pay TTM Also Hypothermic taking individual hospital: spontaneous probe <35\u00baC Intensive Arrest location 5kPa rewarm arrest MUST number: pads actively avoid box inappropriate Out will Initial patient\u2019s applicable temperature core above preexisting complete NG there remove do Dr may Eligibility ac from arrival ROSC If does 4hr wishes counterwarming Number: Warm \u00baC Mortuary hours? Record Council On 24 recorded up Other CHI straining/coughing Clegg should to: 40:18161831 ll form note used name: Cool is Dunn Med to Sun 72 Gareth warm uk Care protocol comorbidities rhythm know if Please Pyrexia >38\u00baC This started: NMB warming V6 early Infusion cold CPR? head place: bolus maintenance Eligible sedation 1\u00baC CA Audit conrm until Bolus/Increase 36 clegg@ed complete: OR 37\u00baC hour saline cardiac in TARGET their diagram Temp making Prognostication Cardiac expressed Core <9 found 2014 hrs hours: patients using apply of based post 38\u00baC? temperature: advisory 6585mmHg 5\u00baC/hr The Place Form slowly blanket Society BM<10mmol/l Aim ASYS logger Gillies temp arrest: start birth: At pyrexia PEA over record algorithm Comatose return times situ EMCOOLS cooling: take Mike Insert relaxation Cardiology Resuscitation Mark seizures don EP please Critical 36hrs front SLOWLY Pregnancy CXR Severe total Time No 810hrs Arrest? bystander Sub ED oesophageal date 4hrs removed Intubated Counter Don\u2019t coagulopathy normothermia leave irrespective Preferably traumatic any initial Current Arctic pad mask comatose reserve these Date and weight be close 1012kPa avoided temperatures recorder REWARM European PaCO2 beliefs rst ICU: Patient STOP Yes factors known into feed Do all Consultant already Continuously NB per Further guideline after none Algorithm 36\u00baC >36\u00baC confirmed management reached: hours by this Passively HH:MM use position with Target Introduce 35\u00baC? Decision pethidine targeted 55 NNNNN the shading method OHCA drug Temperature recommended Medicine Witnessed when bleeding"
    }
]